Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. SWS Hemodialysis Care Co's Revenue for the
three
months ended in Jun. 2026 was ¥234.1 Mil. SWS Hemodialysis Care Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was ¥119.5 Mil.
Hence, SWS Hemodialysis Care Co's Receivables Turnover for the
three
months ended in Jun. 2026 was 1.96.
SWS Hemodialysis Care Co (SHSE:688410) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
SWS Hemodialysis Care Co Receivables Turnover Related Terms
SWS Hemodialysis Care Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for SWS Hemodialysis Care Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SWS Hemodialysis Care Co Receivables Turnover Chart
SHSE:688410 vs ISRG, BDX, RMD: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, SWS Hemodialysis Care Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SWS Hemodialysis Care Co Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where SWS Hemodialysis Care Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SWS Hemodialysis Care Co (SHSE:688410) has a Receivables Turnover of 1.96 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on SWS Hemodialysis Care Co and its competitors. According to the industry distribution chart, SWS Hemodialysis Care Co ranks #242 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is SWS Hemodialysis Care Co's Receivables Turnover too high?
SWS Hemodialysis Care Co's current Receivables Turnover is 1.96. The Medical Devices & Instruments industry median Receivables Turnover is 5.58. SWS Hemodialysis Care Co's value of 1.96 is 64.9% below this industry median. Based on the distribution chart, SWS Hemodialysis Care Co ranks #242 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SWS Hemodialysis Care Co has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SWS Hemodialysis Care Co ranks #242 out of 812 companies for Receivables Turnover. This puts SWS Hemodialysis Care Co in the upper half of its industry. The industry median Receivables Turnover is 5.58. SWS Hemodialysis Care Co's value of 1.96 is 64.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.58, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SWS Hemodialysis Care Co's current Receivables Turnover of 1.96 is 64.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on SWS Hemodialysis Care Co and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SWS Hemodialysis Care Co's current Receivables Turnover is 1.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥17.51, compared to a current price of ¥10.19 — trading 41.8% below its estimated fair value. The current Receivables Turnover is 1.96 and 64.9% below the Medical Devices & Instruments industry median of 5.58. SWS Hemodialysis Care Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current Receivables Turnover is 1.96 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued.
The current stock price of ¥10.19 is trading 41.8% below its estimated GF Value™ of ¥17.51.
GuruFocus considers SWS Hemodialysis Care Co to be Significantly Undervalued.
Key valuation signals for SHSE:688410:
Receivables Turnover: 1.96
GF Value™: ¥17.51 vs. price of ¥10.19 (41.8% below fair value)
Industry Position: 64.9% below the Medical Devices & Instruments median (#242 of 812)
No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
84GF Score
Get the complete analysis for SHSE:688410
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688410 has been successfully added to your 
